16 January 2019

Director / PDMR Dealing

The Company today announces that, Hilary Spence, Chief Financial Officer ("CFO") of the Company, was granted options (the "Options") over 1,000,000 ordinary shares of 1 pence each in the share capital of the Company ("Shares") exercisable at a price of 3.85 pence per Share.

The Options will vest in three equal tranches on the first, second and third anniversaries of 3 January 2019. Such vesting will be conditional on her continued employment.  In addition, the ability to exercise any vested Options will be dependent on achieving a closing middle market price per Share of 10 pence at any time after the date of grant and on the Company delivering sustainable positive cash flows from operations for any period of six months. All Options will lapse after 10 years from the date of grant, being 16 January 2019.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Hilary Spence
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Collagen Solutions Plc
b) LEI 213800IFY1CVGRGETL95
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p each

ISIN Code: GB00B94T6Y14
b) Nature of the transaction Grant of options over ordinary shares of 1p each exercisable at 3.85p per share
c) Price(s) and volume(s) Price(s):                                       Volume(s):

0 pence                                      1,000,000

Aggregated information

- Aggregated volume

- Price


N/A

N/A
e) Date of the transaction 16/01/2019
f) Place of the transaction Outside a trading venue

 

Enquiries:

Collagen Solutions Plc Via Walbrook
Jamal Rushdy, CEO  
Hilary Spence, CFO  
   
Cenkos Securities Plc (Nominated Adviser and Broker)  
Steve Cox (Corporate Finance) Tel: 0207 397 8900
Stephen Keys  
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Helen Cresswell Mob: 07841 917 679